Evaluation Of Pessaries In Twin Pregnancies With A Short Cervix (25 mm) Between 20-28 WG (EPEGE)
NCT00502190 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2011-11-10
Summary
Randomized, opened multicentric study evaluating the Effectiveness of Pessary in the patients with a Gemellary pregnancy and a collar runs between 20 and 28 weeks of amenorrhoea
Conditions
- Twin Pregnancy
Interventions
- DEVICE
-
Silicon ring positioned in the vagina, around the cervix
Silicon ring positioned in the vagina, around the cervix
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Jacky NIZARD, CCA · Assistance Publique - Hôpitaux de Paris
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
Countries
- France
Study Locations
More Related Trials
-
Long-Acting Progestin Contraception and the Vaginal Microbiome
NCT02740998 ·Status: COMPLETED
-
Vaginal Micronized Progesterone Versus Levonorgestrel for Treatment of Non-atypical Endometrial Hyperplasia
NCT03992937 ·Status: COMPLETED ·Phase: NA
-
Immediate vs. Delayed Postpartum Etonogestrel Implant
NCT01767285 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety, Efficacy and Cycle Control of a Contraceptive Vaginal Ring
NCT00455156 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)
NCT01166412 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PARIS or PAtch RIng Study: A Trial to Evaluate NuvaRing Versus OrthoEvra
NCT00269620 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
NCT02524288 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women
NCT02451826 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women
NCT02403401 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives
NCT03949985 ·Status: COMPLETED
-
Postpartum Etonogestrel Implant for Adolescents
NCT01666912 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
NCT01948882 ·Status: COMPLETED ·Phase: NA
-
Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
NCT02357368 ·Status: COMPLETED ·Phase: PHASE4
-
Study Evaluating Levonorgestrel and Ethinyl Estradiol in Oral Contraception
NCT00248963 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of Two Contraceptive Vaginal Rings Delivering a Daily Dose of 1500 or 2500 μg of CDB-2914
NCT00791297 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
NCT06668896 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception
NCT00995150 ·Status: TERMINATED ·Phase: PHASE3
-
The Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
NCT01861886 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
NCT02668822 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
NCT02668783 ·Status: TERMINATED ·Phase: PHASE3
-
Oral Contraceptive Pills Versus Levonorgestrel-Releasing Intrauterine System for Niche-Related Abnormal Uterine Bleeding
NCT07229209 ·Status: COMPLETED ·Phase: NA
-
Contraceptive Hormones, Immunity, and Microbiome Evaluation
NCT03660046 ·Status: COMPLETED
-
A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
NCT00161226 ·Status: TERMINATED
-
Ethylvinyl Acetate (EVA) Vaginal Ring Delivery System Study
NCT00706784 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
EC PK in Women With Normal and Obese BMI
NCT02689804 ·Status: COMPLETED ·Phase: PHASE4